EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.7.1.48 | Neoplasms |
5878 |
Inhibition of Newcastle disease virus replication by 6-azauridine. I. Inefficacy of purified uridine kinase, effect of adenosine-5'-triphosphate. |
ongoing research therapeutic application unassigned |
3 2 0 |
2.7.1.48 | Newcastle Disease |
5878 |
Inhibition of Newcastle disease virus replication by 6-azauridine. I. Inefficacy of purified uridine kinase, effect of adenosine-5'-triphosphate. |
ongoing research therapeutic application unassigned |
3 2 0 |
2.7.1.48 | Neoplasms |
14785 |
Coprecipitation of active uridine kinase and phosphomonoesterase from rat kidney by Zn2+-ions. III. Enzymes relevant to cancer chemotherapy. |
ongoing research unassigned |
3 0 |
2.7.1.48 | Lymphoma |
36981 |
Some properties of uridine-cytidine kinase from a human malignant lymphoma. |
ongoing research unassigned |
4 0 |
2.7.1.48 | Liver Neoplasms, Experimental |
50069 |
Early temporal changes in the uridine kinase isozyme profile of the Novikoff hepatoma in response to 5-azacytidine treatment. |
causal interaction therapeutic application unassigned |
4 3 0 |
2.7.1.48 | Leukemia |
66093 |
Uridine kinase activities in normal and neoplastic lymphoid cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 3 3 |
2.7.1.48 | Leukemia, Lymphocytic, Chronic, B-Cell |
66093 |
Uridine kinase activities in normal and neoplastic lymphoid cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 3 3 |
2.7.1.48 | Leukemia, Lymphoid |
66093 |
Uridine kinase activities in normal and neoplastic lymphoid cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 3 3 |
2.7.1.48 | Lymphoma, Non-Hodgkin |
66093 |
Uridine kinase activities in normal and neoplastic lymphoid cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 3 3 |
2.7.1.48 | Mastocytoma |
66093 |
Uridine kinase activities in normal and neoplastic lymphoid cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 3 3 |